Navigation Links
Bahnbrechende hochleistungsfähige Peptidsynthese-Technologie von CEM wird mit R&D 100 Award ausgezeichnet
Date:7/15/2014

MATTHEWS, North Carolina, 15. Juli 2014 /PRNewswire/ -- CEM Corporation, ein führender Anbieter von Mikrowellen-Laborgeräten, gibt erfreut bekannt, das sein automatisierter Mikrowellen-Peptidsynthetisierer Liberty Blue™ einen R&D 100 Award für das Jahr 2014 erhalten hat. Die Auszeichnung wird einmal im Jahr von den Herausgebern des R&D Magazine für die 100 "technologisch bedeutendsten innovativen Produkte und Prozesse des Jahres" verliehen.

Liberty Blue ist eine neuartige, revolutionäre Technologie, mit der die Peptidsynthese drastisch verbessert wird. Das System setzt einen innovativen Prozess zur hocheffizienten mikrowellenbeschleunigten Festphasen-Peptidsynthese (HE-SPPS) der 2. Generation ein, der es möglich macht, Peptide in höherer Reinheit bis zu 25 Mal schneller als mit konventionellen Systemen und 6 Mal schneller als mit zur Zeit erhältlichen Mikrowellensystemen zu synthetisieren. Dies führt zusätzlich zu einer Einsparung von 90% bei Lösemitteln, einem erheblichen Kostenfaktor bei der Peptidsynthese. HE-SPPS ermöglicht die Synthese eines Peptids in weniger als einer Stunde anstelle von Tagen, was eine wesentliche Verbesserung in der Produktion von grundlegenden biologischen Substanzen für die Arzneimittelforschung und viele andere Studienfelder der Biowissenschaften darstellt und gleichzeitig eine signifikante Einsparung bei den Kosten für Aufreinigung und Lösemitteln bedeutet.

"Liberty Blue ist das Ergebnis jahrelanger Forschungsarbeit zum Prozess der Peptidsynthese und ist aufgrund des entscheidenden Bedarfs an Peptiden in den Forschungsbereichen der Pharmazie und Biowissenschaften eines der wichtigsten Produkte, das wir jemals entwickelt haben," e
'/>"/>

SOURCE CEM Corporation
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CEMs Breakthrough High-Efficiency Peptide Synthesis Technology Wins R&D 100 Award
2. Sitari Pharmaceuticals, First Company Launched Through Avalon Ventures-GlaxoSmithKline Collaboration, Raises up to $10 Million Series A Financing and R&D Support
3. Berg en Icahn School of Medicine van het Mount Sinai kondigen R&D- partnerschap aan voor ontdekking en ontwikkeling van geneesmiddelen
4. PTC Therapeutics to Showcase Breadth of Pipeline at Upcoming R&D Day
5. Janssen R&D Ireland Announces Agreement with PATH for Early Development of Rilpivirine in Long-Acting Formulation for Potential Prophylactic Intervention
6. SeraCare Life Sciences Expands R&D Facilities
7. Orphan Drugs for Cancer: R&D and Market 2013-2023
8. CLAAD Lauds Signature Therapeutics R&D Efforts To Reduce Prescription Drug Abuse
9. Return to Growth for Pharmaceutical Sector: Surge in Drug Approvals, R&D Productivity and Investor Confidence to Drive Expansion Through 2018
10. BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects
11. Pharma R&D Model Needs Academic Tech Transfer Collaboration for the Future of Drug Innovation Says New Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... VIENNA , July 31, 2014 ... New York results of AFF008, a Phase ... PD01A is the first therapy against the protein alpha-synuclein, a ... The Michael J. Fox Foundation for Parkinson,s Research (MJFF) supported ... at the press conference on the impact a disease-modifying therapy ...
(Date:7/31/2014)... Astellas has appointed Moyra Knight ... communications in the Americas region. Knight will report ... president, chief communications officer. In this role, Knight ... brand initiatives and reputation management to achieve Astellas, ... South America . She will also lead ...
(Date:7/31/2014)... Calif., July 31, 2014 Cryoport, Inc. (OTCBB: ... period ended June 30, 2014. Recent ... $0.94 million for the three month period ended June ... , Partnered with DHL to further expand Cryoport,s global ... , Advanced support of Immudex, an immunotherapy and ...
Breaking Medicine Technology:First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4Astellas Hires Industry Veteran Moyra Knight as Head of Corporate and Employee Communications 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 3Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 4Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 5Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 6Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 7Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 8
... IRVINE, Calif., Aug. 11, 2011 ChromaDex Corporation ... provides proprietary, science-based solutions and ingredients to the ... industries, today announced financial results for the second ... calculated in accordance with U.S. Generally Accepted Accounting ...
... 2011 Reportlinker.com announces that a ... available in its catalogue: ... - Global Opportunity Assessment, Competitive ... 2017 ...
Cached Medicine Technology:ChromaDex Announces Financial Results for Second Quarter 2011 2ChromaDex Announces Financial Results for Second Quarter 2011 3ChromaDex Announces Financial Results for Second Quarter 2011 4Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 2Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 3Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 4Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 5Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 6Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 7Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 8Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 9Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 10
(Date:7/31/2014)... Scotch Plains, New Jersey (PRWEB) July 31, 2014 ... certified dermatologist by the American Board of Dermatology, fellowship ... approved again by NJ Top Docs. , After extensive ... the National Institutes of Health, Dr. Li completed his ... dermatology training at the University of Pennsylvania in Philadelphia. ...
(Date:7/31/2014)... July 31, 2014 The controversy ... Liebhard LLP notes that Johnson & Johnson’s Ethicon, ... voluntarily remove its power morcellators ( http://www.gynecaremorcellatorlawsuit.com/ ) ... Bloomberg.com, the company said it decided to do ... the devices remain uncertain.* , “In light of ...
(Date:7/31/2014)... Jersey (PRWEB) July 31, 2014 Clifton ... administer the application of topical fluoride treatments to their ... caries and help with tooth sensitivity in patients that ... is an infection that is commonly known as “tooth ... hard tissues of the teeth. , Fluoride ...
(Date:7/31/2014)... Amy Norton HealthDay Reporter ... may not have had fast food, TVs or cigarettes, but ... and a new research review speculates on some reasons why. ... Peru, the Aleutian Islands and the American Southwest, researchers have ... arteries from fatty substances that build up, eventually leading to ...
(Date:7/31/2014)... 2014 The International Bottled Water Association (IBWA) ... channel called “ Bottled Water – Always there when ... vital role bottled water plays in times of natural disasters ... typically a busy period for hurricanes and other forms of ... for people to take a moment to re-assess their risks ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Proudly Presents Approved Provider, Dr. Andrew Li of Warren Skin Care Center 2Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 2Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 3Health News:NJ Top Dentists Approved, Clifton Dental Associates Now Actively Recommending the Application of Topical Fluoride Treatments to Adults 2Health News:No TV or Obesity, But Ancient People Still Had Heart Disease 2Health News:No TV or Obesity, But Ancient People Still Had Heart Disease 3Health News:New Video Showcases Bottled Water’s Important Role in Times of Emergencies 2Health News:New Video Showcases Bottled Water’s Important Role in Times of Emergencies 3Health News:New Video Showcases Bottled Water’s Important Role in Times of Emergencies 4
... 3, 2009Despite the efforts of college students to quit ... Marquette University suggests that an extended trial and error ... begin smoking in high school, another study by faculty ... Antonio provides insights into how graphic cigarette warning labels ...
... of growth and innovation at Click4Care , , POWELL, ... management software suite, today announced the appointment of Rob Gillette ... through the next phase of its development, following its explosive ... addition to leading Click4Care, Gillette will continue as CEO of ...
... , National Study by Guardian Life Insurance Identifies Key ... YORK, June 3 The Guardian Life Insurance Company ... for small and mid-sized companies, today announced the results ... regarding healthcare coverage, including health savings accounts (HSAs) and ...
... Alerts for key stocks. , , Seven Summits Strategic Investments, ... (Note: You may have to copy this link into your ... Alerts cover the following stocks: Chevron Corp. (NYSE: CVX ... AA ), Intuitive Surgical, Inc. (Nasdaq: ISRG ...
... (June 2, 2009) --Researchers affiliated with Natura Therapeutics, Inc., ... have jointly received a one-year, $110,000 Small Business Innovation ... (NIH) National Center for Complementary and Alternative Medicine to ... TeaMem holds promise for preventing and treating ...
... guidelines , TUESDAY, June 2 (HealthDay News) -- In ... gain recommendations, obese women who gained little or no ... who gained more. , Just last week, experts at ... Council updated their gestational weight gain guidelines to urge ...
Cached Medicine News:Health News:Recent smoking-cessation research highlights importance of keeping teens from smoking 2Health News:Click4Care(R) Announces Appointment of Rob Gillette as CEO 2Health News:Guardian Survey Reveals Widespread Lack of Understanding of Health Savings Accounts 2Health News:Guardian Survey Reveals Widespread Lack of Understanding of Health Savings Accounts 3Health News:Guardian Survey Reveals Widespread Lack of Understanding of Health Savings Accounts 4Health News:Critical Alerts for CVX, DOW, AA, ISRG, and CELG Released by Seven Summits Research 2Health News:Critical Alerts for CVX, DOW, AA, ISRG, and CELG Released by Seven Summits Research 3Health News:Natura Therapeutics and USF receive NIH grant to study green tea compound for Alzheimer's 2Health News:Fewer New Pounds in Pregnancy Best for Obese Moms 2Health News:Fewer New Pounds in Pregnancy Best for Obese Moms 3
Malaria (P. fal.) Ag Rapid Test...
This is an antigen-capture assay intended for the detection of histidine-rich protein ll (PfHRP-ll), which is released from Malaria-infected red blood cells....
Malaria P.f. Rapid Test Device...
The Malaria Combo Test is a rapid test for the qualitative detection of Plasmodium falciparum and / or Plasmodium vivax , Plasmodium ovale and Plasmodium malariae antigen in whole blood. This ...
Medicine Products: